FDA.reportPublic FDA data

Application 070082

Type
ANDA
Sponsor
MYLAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FUROSEMIDEFUROSEMIDETABLET;ORAL80MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-0232FurosemidefurosemideMylan Pharmaceuticals Inc.ANDACurrent
0378-0232FurosemidefurosemideMylan Pharmaceuticals Inc.ANDACurrent
0378-0232FurosemidefurosemideMylan Pharmaceuticals Inc.ANDACurrent
0378-0232FurosemidefurosemideMylan Pharmaceuticals Inc.ANDACurrent
50090-2187FurosemidefurosemideA-S Medication SolutionsANDACurrent
51079-527FurosemidefurosemideMylan Institutional Inc.ANDACurrent
51079-527FurosemidefurosemideMylan Institutional Inc.ANDACurrent
51079-527FurosemidefurosemideMylan Institutional Inc.ANDACurrent
51079-527FurosemidefurosemideMylan Institutional Inc.ANDACurrent
53808-0839FurosemidefurosemideState of Florida DOH Central PharmacyANDACurrent
55154-5477FurosemidefurosemideCardinal HealthANDACurrent
63629-1435FurosemidefurosemideBryant Ranch PrepackANDACurrent
70518-1256FurosemidefurosemideREMEDYREPACK INC.ANDACurrent
70518-1256FurosemidefurosemideREMEDYREPACK INC.ANDACurrent